SearchDictionaryMobileLogin

Cataract Extraction

2325  relevant articles (76 outcomes, 154 trials/studies) found for this Therapy

Description: The removal of a cataractous CRYSTALLINE LENS from the eye.

Also Known As:
Phakectomy; Cataract Extractions; Enzymatic Zonulolyses; Extraction, Cataract; Extractions, Cataract; Phakectomies; Zonulolyses, Enzymatic; Zonulolysis, Enzymatic; Enzymatic Zonulolysis

Relationship Network

Therapy Context: Research Results

Experts

1. Madhavan, H N: 3 articles (01/2006 - 03/2000)
2. Lam, Dennis S C: 2 articles (11/2007 - 08/2003)
3. Azuara-Blanco, Augusto: 2 articles (03/2007 - 08/2003)
4. Schleck, Cathy D: 2 articles (11/2006 - 01/2006)
5. Baratz, Keith H: 2 articles (11/2006 - 01/2006)
6. Robertson, Dennis M: 2 articles (11/2006 - 01/2006)
7. Erie, Jay C: 2 articles (11/2006 - 01/2006)
8. Biswas, J: 2 articles (07/2000 - 03/2000)
9. Apple, D J: 2 articles (03/2000 - 02/2000)
10. Kawji, Shahem: 1 article (07/2008)

Related Diseases

1. Cataract (Cataracts)
2. Glaucoma
3. Inflammation
4. Wounds and Injuries (Trauma)
5. Macular Edema
06/01/2008 - "CONCLUSIONS: The results in this study suggest that AquaLase liquefaction cataract extraction is as safe as standard US phacoemulsification cataract extraction and may carry less risk for the development of postoperative cystoid macular edema"
02/01/1988 - "A previous study by one of the authors found no significant difference in the incidence of cystoid macular edema with an intracapsular cataract extraction and the implantation of an iris-supported posterior chamber optic lens, compared with the incidence of cystoid macular edema with an extracapsular extraction and the implantation of a Shearing lens"
07/01/1983 - "A prospective clinical study has been undertaken to determine the rate of clinical cystoid macular edema in a population that has had intracapsular cataract extraction with the implantation of an iris-supported posterior lens"
11/01/1979 - "An on-going study of results and complications in a series of 1055 cataract extractions, done by Kelman phacoemulsification with up to five and one-half years' follow-up, showed that the incidence of cystoid macular edema (CME) is significantly less when the posterior capsule is left intact"
06/18/2007 - "3) In the context of good glycemic control, does a strategy targeting a systolic blood pressure level <120 mm Hg reduce development and progression of DR compared with one targeting a level <140 mm Hg? Secondary outcome variables include various levels of loss of visual acuity at 4 years versus baseline, cataract extraction, and the development or progression of diabetic macular edema"
Order ALL the reference details at left...

Related Drugs and Biologics

1. Argon
2. Prednisolone (Predate)
3. Povidone-Iodine (Betadine)
4. Indomethacin (Indometacin)
5. Diclofenac (SR 38)
6. Ophthalmic Solutions (Eye Drops)
7. Fluorescein (Funduscein)
8. chymotrypsin A
9. Ketorolac Tromethamine (Acular)
10. rimexolone (Vexol)

Related Therapies and Procedures

1. Phacoemulsification
2. Intraocular Lenses (Intraocular Lens)
3. Intraocular Lens Implantation
4. Trabeculectomy (Trabeculoplasty)
5. Vitrectomy

Best Treatments:
Research Summary Report
on Cataract

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 587 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>